Sponsor

University of Chicago

Clinical research sponsor

Published trials313
Recruiting shown38
Roles2
SourceClinicalTrials.gov

Clinical trials

60 shown
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung CancerNCT07603856 · lead sponsor · 2026-12-12
RECRUITING
Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer TreatmentNCT07553234 · lead sponsor · 2026-09-21
RECRUITING
BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIVNCT07502365 · lead sponsor · 2026-07-29
RECRUITING
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly PatientsNCT06824818 · lead sponsor · 2026-06-01
RECRUITING
Transition Care for FEPNCT07713849 · lead sponsor · 2026-05-06
RECRUITING
Geriatric Assessment and Technology Evaluation in Prostate CancerNCT06215508 · lead sponsor · 2026-04-01
RECRUITING
Achieving Routine Intervention and Screening for Emotional HealthNCT06887049 · lead sponsor · 2026-03-10
RECRUITING
Partial Pleurectomy (Surgery) for Unresectable Pleural MesotheliomaNCT07126509 · lead sponsor · 2025-12-02
RECRUITING
PSMA PET for Surveillance After Focal TherapyNCT07115914 · lead sponsor · 2025-11-19
RECRUITING
Type 1 Diabetes and Obstructive Sleep ApneaNCT06915831 · lead sponsor · 2025-11-10
RECRUITING
Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)NCT06785324 · lead sponsor · 2025-05-12
RECRUITING
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate AblationNCT05790213 · lead sponsor · 2025-05-05
RECRUITING
Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority MenNCT06894199 · lead sponsor · 2025-04-22
RECRUITING
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial FibrillationNCT06499857 · lead sponsor · 2025-04-14
RECRUITING
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast CancerNCT06291064 · lead sponsor · 2025-03-18
RECRUITING
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After SurgeryNCT06348134 · lead sponsor · 2025-03-18
RECRUITING
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerNCT05726292 · lead sponsor · 2025-01-06
RECRUITING
Intensive Patient Referral and Education Program Prior to Renal Replacement TherapyNCT06397456 · lead sponsor · 2024-09-04
RECRUITING
Communication Bridge 3 StudyNCT06191198 · lead sponsor · 2024-08-23
RECRUITING
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key PopulationsNCT06477588 · lead sponsor · 2024-08-13
RECRUITING
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)NCT06705803 · lead sponsor · 2024-06-21
RECRUITING
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver TransplantNCT06950788 · lead sponsor · 2024-03-12
RECRUITING
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of LifeNCT06171269 · lead sponsor · 2024-01-05
RECRUITING
Cardiac Power Output in Cardiogenic Shock PatientsNCT05700617 · lead sponsor · 2023-07-06
RECRUITING
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyNCT05710380 · lead sponsor · 2023-04-26
RECRUITING
Predict Severe Traumatic Brain InjuryNCT06966713 · lead sponsor · 2023-02-20
RECRUITING
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support InterventionNCT05723653 · lead sponsor · 2023-02-13
RECRUITING
GI Oxalate AbsorptionNCT05356000 · lead sponsor · 2023-01-25
RECRUITING
Case Management DyadNCT06162897 · lead sponsor · 2022-09-09
RECRUITING
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)NCT05068232 · lead sponsor · 2022-08-19
RECRUITING
MRI Screening in Men at High Risk of Developing Prostate CancerNCT05608694 · lead sponsor · 2022-03-02
RECRUITING
Diabetic Neuropathy in Spinal Cord Stimulator PatientsNCT04687215 · lead sponsor · 2022-01-27
RECRUITING
Olaparib in Patients With HRD Malignant MesotheliomaNCT04515836 · lead sponsor · 2021-02-19
RECRUITING
Aspirin and PreeclampsiaNCT04479072 · lead sponsor · 2021-02-15
RECRUITING
A Multi-Modality Surveillance Program for Women at High Risk for Breast CancerNCT03729115 · lead sponsor · 2019-05-30
RECRUITING
Vasoactive Drugs in Intensive Care UnitNCT02118467 · lead sponsor · 2014-05-15
RECRUITING
Islet Transplantation in Patients With "Brittle" Type I DiabetesNCT01630850 · lead sponsor · 2012-05-01
RECRUITING
Islet Transplantation in Type 1 Diabetic Kidney AllograftNCT01241864 · lead sponsor · 2010-12-01
RECRUITING
Mobile Health Management of HypertensionNCT05856955 · lead sponsor · 2027-09-01
NOT_YET_RECRUITING
Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)NCT07808333 · lead sponsor · 2027-06-01
NOT_YET_RECRUITING
Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV CareNCT07847567 · lead sponsor · 2027-02-01
NOT_YET_RECRUITING
Leveraging Pharmacy Technicians to Advance the Reach of Modern Antiretroviral Therapy (PHARM ART) in Community ClinicsNCT07553949 · lead sponsor · 2027-01-01
NOT_YET_RECRUITING
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.NCT06660862 · lead sponsor · 2026-11-01
NOT_YET_RECRUITING
Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity RiskNCT03000803 · lead sponsor · 2026-10-01
WITHDRAWN
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving LorlatinibNCT07782359 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational DiabetesNCT07034261 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, KenyaNCT06790342 · lead sponsor · 2026-07-31
NOT_YET_RECRUITING
CommunityRx-Dementia + Peer Navigation (CRxDpeer)NCT07346183 · lead sponsor · 2026-06-01
NOT_YET_RECRUITING
N2O for Acute Suicidality and Depression in the EDNCT05710887 · lead sponsor · 2026-02-27
WITHDRAWN
Mood Effects of Serotonin Agonists: DepressionNCT07017478 · lead sponsor · 2025-06-09
COMPLETED
Telehealth Education Leveraging Electronic Transitions Of Care for COPD PatientsNCT05897125 · lead sponsor · 2025-02-19
ENROLLING_BY_INVITATION
Achieving Equity in Patient Outcome Reporting for Timely Assessments of Life With HIV and Substance UseNCT06682468 · lead sponsor · 2025-02-12
ACTIVE_NOT_RECRUITING
Communication Bridge Pilot StudyNCT06211374 · lead sponsor · 2024-06-28
ACTIVE_NOT_RECRUITING
Virtual Diabetes Group Visits Across Health SystemsNCT06094491 · lead sponsor · 2024-05-03
ACTIVE_NOT_RECRUITING
Localized Body Cooling Technology on Sleep and Metabolism in African, American With Overweight and ObesityNCT05849181 · lead sponsor · 2024-03-25
COMPLETED
Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)NCT06305286 · lead sponsor · 2024-03-04
ACTIVE_NOT_RECRUITING
Patient Satisfaction With Abbreviated Postpartum Magnesium Sulfate for Severe PreeclampsiaNCT05789381 · lead sponsor · 2024-03-01
WITHDRAWN
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory IssuesNCT06171152 · lead sponsor · 2024-01-26
SUSPENDED
Sleep Extension or Regularity to Reduce Diabetes RiskNCT06128265 · lead sponsor · 2024-01-03
COMPLETED
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality DisorderNCT05399498 · lead sponsor · 2023-11-01
COMPLETED

Sponsor roles

lead sponsor241
collaborator72

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.